Found 477 results in Expert Content

Summary: This executive summary highlights lipid-based formulations (LBFs) in pharmaceutical development, emphasizing their complex composition and the critical role of careful formulation selection in the early stages of drug development.

Summary: Watch this video as experts discuss the complexities and opportunities for lipid-based formulations to improve drug delivery.

Summary: In this webinar industry experts delve into HME principles, mechanisms, and advantages over traditional methods

Summary: In this webinar experts share insights into critical considerations & strategies for dosing lipid formulations in preclinical models

During this webinar, industry experts will navigate the intricate journey of drug development, exploring how minitablets have redefined formulation strategies, efficacy, and patient-centric solutions as well as options for lifecycle management.

Read this case study to learn how a company engaged with Catalent to develop an oral lipid-based formulation that would lead to a more predictable and reliable drug response.

Summary: Explore Catalent’s extensive standalone analytical services with industry leading equipment and network of over 3,000 scientists. Learn how our deep expertise supporting pharmaceuticals, biologics (protein, cell and therapy, and vaccines), inhalation (nasal and dry powder inhaler), drug product/substance and in-process samples could help accelerate your drug product's journey.

In this webinar, experts discuss problems common to the development, testing and manufacturing of intranasal drug products, their potential causes, and possible consequences.

Summary: In this webinar, experts will explore the current investment and clinical landscape of Targeted Protein Degraders.

In a Fireside Chat during the 2024 JP Morgan Healthcare Conference, Catalent President & CEO Alessandro Maselli shared his predictions for 2024 and his thoughts on the top risks and opportunities in Biotech with Endpoints News Editor John Carroll.